04:38 PM EDT, 03/27/2026 (MT Newswires) -- James Edgemond, CFO and Treasurer, on March 26, 2026, sold 10,000 shares in United Therapeutics ( UTHR ) for $5,359,005. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000163617826000004/xslF345X05/primarydocument.xml